1.0Asthma and Allergy Foundation of Americahttps://aafa.orgMelanie Carverhttps://aafa.org/author/melanie-carver/Patient Focused Drug Development: Eczemarich600338<blockquote class="wp-embedded-content" data-secret="lRDNFAlT02"><a href="https://aafa.org/asthma-allergy-research/our-research/patient-focused-drug-development-for-atopic-dermatitis/">Patient Focused Drug Development: Eczema</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://aafa.org/asthma-allergy-research/our-research/patient-focused-drug-development-for-atopic-dermatitis/embed/#?secret=lRDNFAlT02" width="600" height="338" title="“Patient Focused Drug Development: Eczema” — Asthma and Allergy Foundation of America" data-secret="lRDNFAlT02" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://aafa.org/wp-includes/js/wp-embed.min.js
</script>
AAFA has partnered with four other patient groups to host a Patient Focused Drug Development meeting on September 23rd in the Washington, D.C. area. The meeting will help the U.S. Food and Drug Administration (FDA) and researchers to better understand the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative!